Chemical & Bioprocess Engineering - Biopharmaceutical Engineering
MEngSc Biopharmaceutical Engineering
Graduate Taught (level 9 nfq, credits 90)
Pharmaceutical and Biopharmaceutical manufacturing are key sectors in the Irish economy generating over 50 per cent of GDP. This sector has seen continued and sustained success with a number of high-profile investments in recent years providing excellent job opportunities for graduates. The programme and its academic faculty are closely linked with the National Institute for Bioprocessing Research and Training (NIBRT), which is a global centre of excellence for training and research in bioprocessing.
The MEngSc in Biopharmaceutical Engineering programme provides substantial coverage of scientific, technical, management and regulatory issues associated with this industry. The aim of this programme is to offer an internationally recognised high-quality flexible curriculum, which follows the latest developments in science and technology. This programme is suitable for Science and Engineering graduates wishing to obtain a qualification which is highly relevant to the biopharmaceutical industry.
This programme has an excellent employment record. It equips graduates with an internationally recognised qualification and the knowledge and skills to obtain a high level professional career in the Biopharmaceutical, Pharmaceutical and related sectors.
Who should apply?
Full Time option suitable for:
Domestic(EEA) applicants: Yes
International (Non EEA) applicants currently residing outside of the EEA Region. Yes
Vision and Values Statement
The MEngSc Biopharmaceutical Engineering programme provides intensive training in the requisite skills for a professional engineer or scientist in the biopharmaceutical or related sector. The programme provides substantial coverage of the scientific, technical, management and regulatory issues associated with this industry.
The programme's teaching methods are highly interactive and varied and student learning is assessed using a variety of assessment methodology including exams, assignments, case studies and presentations. Students complete a research project which consolidates their basic knowledge of the course content and provides intensive research experience and training. The course content addresses the principal scientific and engineering challenges involved in the design, operation and management of biopharmaceutical production facilities.
It is anticipated that graduates from this programme will play an important role in the development, design and operation of biopharmaceutical processes throughout the industry in the coming years.
Apply their knowledge of biopharmaceutical production processes to design, equip and manage a biopharmaceutical production factility
Demonstrate an appreciation of the concept and practice of independent research in specialised topics in biopharmaceutical engineering
Demonstrate an integrated knowledge of GMP and the regulatory issues involved in biopharmaceutical production
Demonstrate an understanding and appreciation of the challenges involved in the downstream purification of biopharmaceuticals
Demonstrate an understanding of the fundamentals of process control when applied to growth of mammalian cells in bioreactors
Demonstrate an understanding of the scientific principles involved in the development of a biopharmaceutical production process
Demonstrate the ability to work as part of a design team for the development of a new production facility
Understand the engineering principles underlying the production of biopharmaceuticals
Stage 1 - Core
Animal Cell Culture Technology (FT) CHEN40040
Bioreactor Modelling and Control CHEN40060
Bioprocessing Laboratory CHEN40090
Facility Design and Operation CHEN40110
Bioprocess Scale-up and Technology Transfer CHEN40130
Biopharmaceutical Engineering Project CHEN40140
Downstream Processing CHEN40460
Lean Sigma Biopharma Process CHEN40480
Bioprocess Design CHEN40530
Bioanalytical Science for Biopharma CHEN40630
Data Sci for Biopharm Manufact CHEN40770
Regulatory Affairs in Science PHAR40240
Stage 1 - Option
Principles of Biopharmaceutical Engineering (FT) CHEN40020
Biotechnology & Biopharma CHEN40670
An honours undergraduate degree (NFQ level 8) with a minimum upper second class honours or international equivalence in a relevant Engineering, Science or Technology programme. However, all applicants will be assessed on a case-by-case basis and relevant or extensive work experience will be taken into account.
Applicants whose first language is not English must also demonstrate English language proficiency of IELTS 6.5 (no band less than 6.0 in each element), or equivalent.
These are the minimum entry requirements – additional criteria may be requested for some programmes
The following entry routes are available:
MEngSc Biopharmaceutical Engineering FT (T070)
Duration 1 Years Attend Full Time
* Courses will remain open until such time as all places have been filled, therefore early application is advised
1 year full-time.
MEngSc Biopharmaceutical Engineering (T070) Full Time
EU fee per year - € 8085
nonEU fee per year - € 25600
***Fees are subject to change
Please note that UCD offers a number of graduate scholarships for full-time, self-funding international students, holding an offer of a place on a UCD graduate degree programme. For further information please see http://www.ucd.ie/global/study-at-ucd/scholarshipsfinances/scholarships/.
The College of Engineering & Architecture also offer scholarships for non-EU students, for more information see: www.ucd.ie/eacollege/study/noneuscholarships.
Next Intake: 2020/2021 September
Post Course Info
Career & Graduate Study Opportunity
Your career opportunities upon graduation from this programme are exemplary. Ireland is a world player in pharmaceutical and biopharmaceutical production.
The pharmaceutical industry in Ireland comprises a mix of international and local companies. Approximately, 120 overseas companies have plants in Ireland, including many of the largest pharmaceutical and biopharmaceutical companies in the world including AbbVie, Amgen, Biomarin, BMS, Genzyme, GSK, Janssen Biologics (Ireland), Merck, Novartis, Pfizer, Regeneron, Roche, Sanofi Shire, and many more. Upon graduation from this programme, you will enjoy an extremely high job placement rate with superlative career opportunities.